nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CALM1—Alzheimer's disease	0.189	0.415	CbGaD
Pimozide—HTR6—Alzheimer's disease	0.17	0.374	CbGaD
Pimozide—HTR2A—Donepezil—Alzheimer's disease	0.0741	0.266	CbGbCtD
Pimozide—DRD2—Memantine—Alzheimer's disease	0.0591	0.213	CbGbCtD
Pimozide—HTR2A—Alzheimer's disease	0.0501	0.11	CbGaD
Pimozide—CYP2D6—Alzheimer's disease	0.0458	0.101	CbGaD
Pimozide—CYP2D6—Rivastigmine—Alzheimer's disease	0.0308	0.111	CbGbCtD
Pimozide—CYP2C19—Memantine—Alzheimer's disease	0.0281	0.101	CbGbCtD
Pimozide—CYP2D6—Donepezil—Alzheimer's disease	0.0246	0.0886	CbGbCtD
Pimozide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0196	0.0705	CbGbCtD
Pimozide—CYP2D6—Galantamine—Alzheimer's disease	0.0159	0.0571	CbGbCtD
Pimozide—CYP3A4—Donepezil—Alzheimer's disease	0.0157	0.0563	CbGbCtD
Pimozide—CYP3A4—Galantamine—Alzheimer's disease	0.0101	0.0363	CbGbCtD
Pimozide—DRD3—telencephalic ventricle—Alzheimer's disease	0.00353	0.072	CbGeAlD
Pimozide—HTR2A—choroid plexus—Alzheimer's disease	0.00336	0.0685	CbGeAlD
Pimozide—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00224	0.0456	CbGeAlD
Pimozide—HTR2A—locus ceruleus—Alzheimer's disease	0.00208	0.0423	CbGeAlD
Pimozide—HTR2A—cerebellar cortex—Alzheimer's disease	0.00169	0.0345	CbGeAlD
Pimozide—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00165	0.0337	CbGeAlD
Pimozide—DRD2—telencephalic ventricle—Alzheimer's disease	0.00149	0.0304	CbGeAlD
Pimozide—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.0012	0.0101	CcSEcCtD
Pimozide—CACNA1G—telencephalon—Alzheimer's disease	0.00119	0.0243	CbGeAlD
Pimozide—Hyperreflexia—Rivastigmine—Alzheimer's disease	0.00118	0.00995	CcSEcCtD
Pimozide—Grand mal convulsion—Memantine—Alzheimer's disease	0.00117	0.00987	CcSEcCtD
Pimozide—Faecal incontinence—Memantine—Alzheimer's disease	0.0011	0.00931	CcSEcCtD
Pimozide—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00109	0.00918	CcSEcCtD
Pimozide—Faecal incontinence—Rivastigmine—Alzheimer's disease	0.00108	0.00911	CcSEcCtD
Pimozide—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00106	0.00898	CcSEcCtD
Pimozide—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00105	0.00886	CcSEcCtD
Pimozide—Body temperature decreased—Memantine—Alzheimer's disease	0.000992	0.00838	CcSEcCtD
Pimozide—Hypothermia—Memantine—Alzheimer's disease	0.000992	0.00838	CcSEcCtD
Pimozide—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000984	0.0201	CbGeAlD
Pimozide—Body temperature decreased—Rivastigmine—Alzheimer's disease	0.00097	0.0082	CcSEcCtD
Pimozide—Hypothermia—Rivastigmine—Alzheimer's disease	0.00097	0.0082	CcSEcCtD
Pimozide—Electrocardiogram abnormal—Donepezil—Alzheimer's disease	0.000934	0.0079	CcSEcCtD
Pimozide—HTR6—forebrain—Alzheimer's disease	0.000887	0.0181	CbGeAlD
Pimozide—Electrocardiogram QT prolonged—Memantine—Alzheimer's disease	0.000866	0.00732	CcSEcCtD
Pimozide—Nocturia—Galantamine—Alzheimer's disease	0.000852	0.0072	CcSEcCtD
Pimozide—Electrocardiogram abnormal—Memantine—Alzheimer's disease	0.000848	0.00717	CcSEcCtD
Pimozide—Electrocardiogram QT prolonged—Rivastigmine—Alzheimer's disease	0.000847	0.00716	CcSEcCtD
Pimozide—Electrocardiogram abnormal—Rivastigmine—Alzheimer's disease	0.00083	0.00701	CcSEcCtD
Pimozide—Cataract—Galantamine—Alzheimer's disease	0.00083	0.00701	CcSEcCtD
Pimozide—OPRK1—forebrain—Alzheimer's disease	0.000821	0.0168	CbGeAlD
Pimozide—Menstrual disorder—Memantine—Alzheimer's disease	0.000816	0.00689	CcSEcCtD
Pimozide—HTR6—telencephalon—Alzheimer's disease	0.000815	0.0166	CbGeAlD
Pimozide—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.000813	0.00687	CcSEcCtD
Pimozide—CALM2—blood vessel—Alzheimer's disease	0.000804	0.0164	CbGeAlD
Pimozide—CALM1—blood vessel—Alzheimer's disease	0.0008	0.0163	CbGeAlD
Pimozide—Torsade de pointes—Memantine—Alzheimer's disease	0.000793	0.0067	CcSEcCtD
Pimozide—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00079	0.00668	CcSEcCtD
Pimozide—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.000767	0.00648	CcSEcCtD
Pimozide—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000738	0.00624	CcSEcCtD
Pimozide—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.000722	0.0061	CcSEcCtD
Pimozide—CACNA1G—nervous system—Alzheimer's disease	0.000702	0.0143	CbGeAlD
Pimozide—Hyperkinesia—Galantamine—Alzheimer's disease	0.000689	0.00582	CcSEcCtD
Pimozide—CACNA1G—central nervous system—Alzheimer's disease	0.000676	0.0138	CbGeAlD
Pimozide—Endocrine disorder—Memantine—Alzheimer's disease	0.000671	0.00567	CcSEcCtD
Pimozide—CACNA1G—cerebellum—Alzheimer's disease	0.00066	0.0135	CbGeAlD
Pimozide—Nocturia—Donepezil—Alzheimer's disease	0.00066	0.00558	CcSEcCtD
Pimozide—Sertindole—HTR6—Alzheimer's disease	0.000654	0.218	CrCbGaD
Pimozide—Speech disorder—Memantine—Alzheimer's disease	0.000646	0.00546	CcSEcCtD
Pimozide—Cataract—Donepezil—Alzheimer's disease	0.000643	0.00544	CcSEcCtD
Pimozide—Speech disorder—Rivastigmine—Alzheimer's disease	0.000632	0.00534	CcSEcCtD
Pimozide—Abnormal dreams—Donepezil—Alzheimer's disease	0.000605	0.00511	CcSEcCtD
Pimozide—Eructation—Donepezil—Alzheimer's disease	0.000602	0.00508	CcSEcCtD
Pimozide—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000595	0.00502	CcSEcCtD
Pimozide—Dyskinesia—Memantine—Alzheimer's disease	0.000591	0.005	CcSEcCtD
Pimozide—Nocturia—Rivastigmine—Alzheimer's disease	0.000586	0.00495	CcSEcCtD
Pimozide—OPRM1—forebrain—Alzheimer's disease	0.000584	0.0119	CbGeAlD
Pimozide—Cataract—Memantine—Alzheimer's disease	0.000584	0.00493	CcSEcCtD
Pimozide—Dyskinesia—Rivastigmine—Alzheimer's disease	0.000579	0.00489	CcSEcCtD
Pimozide—Cataract—Rivastigmine—Alzheimer's disease	0.000571	0.00483	CcSEcCtD
Pimozide—Eructation—Memantine—Alzheimer's disease	0.000546	0.00462	CcSEcCtD
Pimozide—Urinary retention—Galantamine—Alzheimer's disease	0.000545	0.00461	CcSEcCtD
Pimozide—OPRM1—telencephalon—Alzheimer's disease	0.000537	0.011	CbGeAlD
Pimozide—CACNA1G—brain—Alzheimer's disease	0.000536	0.0109	CbGeAlD
Pimozide—Eructation—Rivastigmine—Alzheimer's disease	0.000534	0.00452	CcSEcCtD
Pimozide—CHRM2—forebrain—Alzheimer's disease	0.000532	0.0108	CbGeAlD
Pimozide—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000528	0.00446	CcSEcCtD
Pimozide—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.000524	0.00443	CcSEcCtD
Pimozide—DRD3—nervous system—Alzheimer's disease	0.0005	0.0102	CbGeAlD
Pimozide—CALM3—telencephalon—Alzheimer's disease	0.000496	0.0101	CbGeAlD
Pimozide—Dysphagia—Galantamine—Alzheimer's disease	0.000496	0.00419	CcSEcCtD
Pimozide—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.000492	0.00416	CcSEcCtD
Pimozide—CHRM2—telencephalon—Alzheimer's disease	0.000489	0.00997	CbGeAlD
Pimozide—HTR2A—blood vessel—Alzheimer's disease	0.000487	0.00994	CbGeAlD
Pimozide—Hyperkinesia—Memantine—Alzheimer's disease	0.000485	0.0041	CcSEcCtD
Pimozide—DRD3—central nervous system—Alzheimer's disease	0.000481	0.00982	CbGeAlD
Pimozide—HTR6—nervous system—Alzheimer's disease	0.000481	0.00982	CbGeAlD
Pimozide—CALM2—embryo—Alzheimer's disease	0.000479	0.00978	CbGeAlD
Pimozide—Flunarizine—CALM1—Alzheimer's disease	0.000479	0.16	CrCbGaD
Pimozide—CALM1—embryo—Alzheimer's disease	0.000477	0.00973	CbGeAlD
Pimozide—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000475	0.00402	CcSEcCtD
Pimozide—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000474	0.00401	CcSEcCtD
Pimozide—Increased appetite—Donepezil—Alzheimer's disease	0.000473	0.004	CcSEcCtD
Pimozide—HTR6—central nervous system—Alzheimer's disease	0.000463	0.00946	CbGeAlD
Pimozide—Pollakiuria—Galantamine—Alzheimer's disease	0.000458	0.00387	CcSEcCtD
Pimozide—Weight decreased—Galantamine—Alzheimer's disease	0.000448	0.00379	CcSEcCtD
Pimozide—Hyponatraemia—Donepezil—Alzheimer's disease	0.000446	0.00377	CcSEcCtD
Pimozide—OPRK1—nervous system—Alzheimer's disease	0.000446	0.00909	CbGeAlD
Pimozide—Depression—Galantamine—Alzheimer's disease	0.000441	0.00372	CcSEcCtD
Pimozide—HTR1A—forebrain—Alzheimer's disease	0.000431	0.0088	CbGeAlD
Pimozide—Increased appetite—Memantine—Alzheimer's disease	0.000429	0.00363	CcSEcCtD
Pimozide—OPRK1—central nervous system—Alzheimer's disease	0.000429	0.00875	CbGeAlD
Pimozide—CALM2—forebrain—Alzheimer's disease	0.000424	0.00865	CbGeAlD
Pimozide—Urinary retention—Donepezil—Alzheimer's disease	0.000423	0.00357	CcSEcCtD
Pimozide—CALM1—forebrain—Alzheimer's disease	0.000422	0.00861	CbGeAlD
Pimozide—Increased appetite—Rivastigmine—Alzheimer's disease	0.00042	0.00355	CcSEcCtD
Pimozide—OPRK1—cerebellum—Alzheimer's disease	0.000419	0.00856	CbGeAlD
Pimozide—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000406	0.00343	CcSEcCtD
Pimozide—Hyponatraemia—Memantine—Alzheimer's disease	0.000405	0.00342	CcSEcCtD
Pimozide—Cramp muscle—Donepezil—Alzheimer's disease	0.0004	0.00338	CcSEcCtD
Pimozide—HTR1A—telencephalon—Alzheimer's disease	0.000397	0.00809	CbGeAlD
Pimozide—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000396	0.00335	CcSEcCtD
Pimozide—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00039	0.00329	CcSEcCtD
Pimozide—CALM2—telencephalon—Alzheimer's disease	0.00039	0.00795	CbGeAlD
Pimozide—DRD2—forebrain—Alzheimer's disease	0.00039	0.00795	CbGeAlD
Pimozide—CALM1—telencephalon—Alzheimer's disease	0.000388	0.00792	CbGeAlD
Pimozide—Dysphagia—Donepezil—Alzheimer's disease	0.000384	0.00325	CcSEcCtD
Pimozide—KCNH2—forebrain—Alzheimer's disease	0.000384	0.00783	CbGeAlD
Pimozide—Urinary retention—Memantine—Alzheimer's disease	0.000384	0.00324	CcSEcCtD
Pimozide—Visual impairment—Galantamine—Alzheimer's disease	0.000382	0.00323	CcSEcCtD
Pimozide—DRD3—brain—Alzheimer's disease	0.000382	0.0078	CbGeAlD
Pimozide—Eosinophilia—Donepezil—Alzheimer's disease	0.00038	0.00321	CcSEcCtD
Pimozide—Urinary retention—Rivastigmine—Alzheimer's disease	0.000375	0.00317	CcSEcCtD
Pimozide—Eye disorder—Galantamine—Alzheimer's disease	0.000371	0.00313	CcSEcCtD
Pimozide—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000369	0.00311	CcSEcCtD
Pimozide—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000368	0.00311	CcSEcCtD
Pimozide—Cardiac disorder—Galantamine—Alzheimer's disease	0.000368	0.00311	CcSEcCtD
Pimozide—HTR6—brain—Alzheimer's disease	0.000368	0.00751	CbGeAlD
Pimozide—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000361	0.00305	CcSEcCtD
Pimozide—DRD2—telencephalon—Alzheimer's disease	0.000358	0.00731	CbGeAlD
Pimozide—Breast disorder—Rivastigmine—Alzheimer's disease	0.000357	0.00301	CcSEcCtD
Pimozide—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000355	0.003	CcSEcCtD
Pimozide—Pollakiuria—Donepezil—Alzheimer's disease	0.000355	0.003	CcSEcCtD
Pimozide—KCNH2—telencephalon—Alzheimer's disease	0.000353	0.0072	CbGeAlD
Pimozide—Weight increased—Donepezil—Alzheimer's disease	0.00035	0.00295	CcSEcCtD
Pimozide—Dysphagia—Memantine—Alzheimer's disease	0.000349	0.00295	CcSEcCtD
Pimozide—Mental disorder—Galantamine—Alzheimer's disease	0.000348	0.00294	CcSEcCtD
Pimozide—Weight decreased—Donepezil—Alzheimer's disease	0.000348	0.00294	CcSEcCtD
Pimozide—Depression—Donepezil—Alzheimer's disease	0.000341	0.00289	CcSEcCtD
Pimozide—Dysphagia—Rivastigmine—Alzheimer's disease	0.000341	0.00288	CcSEcCtD
Pimozide—OPRK1—brain—Alzheimer's disease	0.000341	0.00695	CbGeAlD
Pimozide—Muscle spasms—Galantamine—Alzheimer's disease	0.000332	0.00281	CcSEcCtD
Pimozide—Pancytopenia—Memantine—Alzheimer's disease	0.000331	0.0028	CcSEcCtD
Pimozide—Sweating—Donepezil—Alzheimer's disease	0.000328	0.00277	CcSEcCtD
Pimozide—Vision blurred—Galantamine—Alzheimer's disease	0.000325	0.00275	CcSEcCtD
Pimozide—Tremor—Galantamine—Alzheimer's disease	0.000324	0.00273	CcSEcCtD
Pimozide—Pollakiuria—Memantine—Alzheimer's disease	0.000322	0.00272	CcSEcCtD
Pimozide—Erectile dysfunction—Memantine—Alzheimer's disease	0.000321	0.00271	CcSEcCtD
Pimozide—ABCB1—blood vessel—Alzheimer's disease	0.000319	0.00651	CbGeAlD
Pimozide—Anaemia—Galantamine—Alzheimer's disease	0.000319	0.0027	CcSEcCtD
Pimozide—Weight increased—Memantine—Alzheimer's disease	0.000317	0.00268	CcSEcCtD
Pimozide—Agitation—Galantamine—Alzheimer's disease	0.000317	0.00268	CcSEcCtD
Pimozide—OPRM1—nervous system—Alzheimer's disease	0.000317	0.00647	CbGeAlD
Pimozide—Weight decreased—Memantine—Alzheimer's disease	0.000316	0.00267	CcSEcCtD
Pimozide—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000315	0.00266	CcSEcCtD
Pimozide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000314	0.00266	CcSEcCtD
Pimozide—Weight increased—Rivastigmine—Alzheimer's disease	0.000311	0.00262	CcSEcCtD
Pimozide—Depression—Memantine—Alzheimer's disease	0.00031	0.00262	CcSEcCtD
Pimozide—Syncope—Galantamine—Alzheimer's disease	0.00031	0.00262	CcSEcCtD
Pimozide—Weight decreased—Rivastigmine—Alzheimer's disease	0.000309	0.00261	CcSEcCtD
Pimozide—HRH1—forebrain—Alzheimer's disease	0.000308	0.00628	CbGeAlD
Pimozide—OPRM1—central nervous system—Alzheimer's disease	0.000305	0.00623	CbGeAlD
Pimozide—Palpitations—Galantamine—Alzheimer's disease	0.000305	0.00258	CcSEcCtD
Pimozide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000304	0.00257	CcSEcCtD
Pimozide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000304	0.00257	CcSEcCtD
Pimozide—Depression—Rivastigmine—Alzheimer's disease	0.000303	0.00256	CcSEcCtD
Pimozide—Convulsion—Galantamine—Alzheimer's disease	0.000299	0.00253	CcSEcCtD
Pimozide—Droperidol—HTR2A—Alzheimer's disease	0.000299	0.0997	CrCbGaD
Pimozide—Hypertension—Galantamine—Alzheimer's disease	0.000298	0.00252	CcSEcCtD
Pimozide—Visual impairment—Donepezil—Alzheimer's disease	0.000296	0.0025	CcSEcCtD
Pimozide—Chest pain—Galantamine—Alzheimer's disease	0.000294	0.00248	CcSEcCtD
Pimozide—Myalgia—Galantamine—Alzheimer's disease	0.000294	0.00248	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000292	0.00247	CcSEcCtD
Pimozide—Sweating—Rivastigmine—Alzheimer's disease	0.000292	0.00246	CcSEcCtD
Pimozide—HTR2A—embryo—Alzheimer's disease	0.000291	0.00593	CbGeAlD
Pimozide—Agranulocytosis—Memantine—Alzheimer's disease	0.00029	0.00245	CcSEcCtD
Pimozide—CHRM2—nervous system—Alzheimer's disease	0.000289	0.00589	CbGeAlD
Pimozide—Dry mouth—Galantamine—Alzheimer's disease	0.000288	0.00243	CcSEcCtD
Pimozide—HRH1—telencephalon—Alzheimer's disease	0.000283	0.00577	CbGeAlD
Pimozide—CHRM2—central nervous system—Alzheimer's disease	0.000278	0.00567	CbGeAlD
Pimozide—Shock—Galantamine—Alzheimer's disease	0.000277	0.00234	CcSEcCtD
Pimozide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000276	0.00234	CcSEcCtD
Pimozide—CALM3—cerebellum—Alzheimer's disease	0.000276	0.00563	CbGeAlD
Pimozide—Tachycardia—Galantamine—Alzheimer's disease	0.000275	0.00232	CcSEcCtD
Pimozide—Connective tissue disorder—Memantine—Alzheimer's disease	0.000274	0.00232	CcSEcCtD
Pimozide—Skin disorder—Galantamine—Alzheimer's disease	0.000274	0.00231	CcSEcCtD
Pimozide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000272	0.0023	CcSEcCtD
Pimozide—CYP2E1—telencephalon—Alzheimer's disease	0.000272	0.00555	CbGeAlD
Pimozide—Mental disorder—Donepezil—Alzheimer's disease	0.000269	0.00228	CcSEcCtD
Pimozide—Visual impairment—Memantine—Alzheimer's disease	0.000269	0.00227	CcSEcCtD
Pimozide—Anorexia—Galantamine—Alzheimer's disease	0.000269	0.00227	CcSEcCtD
Pimozide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000268	0.00227	CcSEcCtD
Pimozide—Hypotension—Galantamine—Alzheimer's disease	0.000263	0.00223	CcSEcCtD
Pimozide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000263	0.00222	CcSEcCtD
Pimozide—Eye disorder—Memantine—Alzheimer's disease	0.000261	0.0022	CcSEcCtD
Pimozide—Cardiac disorder—Memantine—Alzheimer's disease	0.000259	0.00219	CcSEcCtD
Pimozide—Muscle spasms—Donepezil—Alzheimer's disease	0.000257	0.00217	CcSEcCtD
Pimozide—HTR2A—forebrain—Alzheimer's disease	0.000257	0.00524	CbGeAlD
Pimozide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000257	0.00217	CcSEcCtD
Pimozide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000255	0.00216	CcSEcCtD
Pimozide—Insomnia—Galantamine—Alzheimer's disease	0.000255	0.00215	CcSEcCtD
Pimozide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000253	0.00214	CcSEcCtD
Pimozide—Vision blurred—Donepezil—Alzheimer's disease	0.000252	0.00213	CcSEcCtD
Pimozide—Tremor—Donepezil—Alzheimer's disease	0.000251	0.00212	CcSEcCtD
Pimozide—Somnolence—Galantamine—Alzheimer's disease	0.000251	0.00212	CcSEcCtD
Pimozide—Sertindole—SLC6A4—Alzheimer's disease	0.00025	0.0836	CrCbGaD
Pimozide—Anaemia—Donepezil—Alzheimer's disease	0.000247	0.00209	CcSEcCtD
Pimozide—Agitation—Donepezil—Alzheimer's disease	0.000246	0.00208	CcSEcCtD
Pimozide—Decreased appetite—Galantamine—Alzheimer's disease	0.000245	0.00207	CcSEcCtD
Pimozide—Mental disorder—Memantine—Alzheimer's disease	0.000245	0.00207	CcSEcCtD
Pimozide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000243	0.00206	CcSEcCtD
Pimozide—OPRM1—brain—Alzheimer's disease	0.000242	0.00494	CbGeAlD
Pimozide—Constipation—Galantamine—Alzheimer's disease	0.000241	0.00204	CcSEcCtD
Pimozide—Syncope—Donepezil—Alzheimer's disease	0.00024	0.00203	CcSEcCtD
Pimozide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000239	0.00202	CcSEcCtD
Pimozide—HTR2A—telencephalon—Alzheimer's disease	0.000236	0.00482	CbGeAlD
Pimozide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000235	0.00199	CcSEcCtD
Pimozide—CYP2D6—forebrain—Alzheimer's disease	0.000234	0.00478	CbGeAlD
Pimozide—HTR1A—nervous system—Alzheimer's disease	0.000234	0.00478	CbGeAlD
Pimozide—Convulsion—Donepezil—Alzheimer's disease	0.000232	0.00196	CcSEcCtD
Pimozide—Hypertension—Donepezil—Alzheimer's disease	0.000231	0.00195	CcSEcCtD
Pimozide—CALM2—nervous system—Alzheimer's disease	0.00023	0.00469	CbGeAlD
Pimozide—CALM1—nervous system—Alzheimer's disease	0.000229	0.00467	CbGeAlD
Pimozide—Vision blurred—Memantine—Alzheimer's disease	0.000229	0.00194	CcSEcCtD
Pimozide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000229	0.00193	CcSEcCtD
Pimozide—Chest pain—Donepezil—Alzheimer's disease	0.000228	0.00193	CcSEcCtD
Pimozide—Myalgia—Donepezil—Alzheimer's disease	0.000228	0.00193	CcSEcCtD
Pimozide—Tremor—Memantine—Alzheimer's disease	0.000228	0.00192	CcSEcCtD
Pimozide—HTR1A—central nervous system—Alzheimer's disease	0.000225	0.0046	CbGeAlD
Pimozide—Anaemia—Memantine—Alzheimer's disease	0.000225	0.0019	CcSEcCtD
Pimozide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000224	0.00189	CcSEcCtD
Pimozide—CALM3—brain—Alzheimer's disease	0.000224	0.00457	CbGeAlD
Pimozide—Agitation—Memantine—Alzheimer's disease	0.000223	0.00189	CcSEcCtD
Pimozide—Dry mouth—Donepezil—Alzheimer's disease	0.000223	0.00188	CcSEcCtD
Pimozide—Tremor—Rivastigmine—Alzheimer's disease	0.000223	0.00188	CcSEcCtD
Pimozide—CALM2—central nervous system—Alzheimer's disease	0.000222	0.00452	CbGeAlD
Pimozide—CHRM2—brain—Alzheimer's disease	0.000221	0.0045	CbGeAlD
Pimozide—CALM1—central nervous system—Alzheimer's disease	0.000221	0.0045	CbGeAlD
Pimozide—HTR1A—cerebellum—Alzheimer's disease	0.00022	0.0045	CbGeAlD
Pimozide—Anaemia—Rivastigmine—Alzheimer's disease	0.00022	0.00186	CcSEcCtD
Pimozide—Agitation—Rivastigmine—Alzheimer's disease	0.000218	0.00185	CcSEcCtD
Pimozide—Syncope—Memantine—Alzheimer's disease	0.000218	0.00184	CcSEcCtD
Pimozide—Leukopenia—Memantine—Alzheimer's disease	0.000218	0.00184	CcSEcCtD
Pimozide—CALM2—cerebellum—Alzheimer's disease	0.000217	0.00442	CbGeAlD
Pimozide—CALM1—cerebellum—Alzheimer's disease	0.000216	0.0044	CbGeAlD
Pimozide—CYP2D6—telencephalon—Alzheimer's disease	0.000215	0.00439	CbGeAlD
Pimozide—Shock—Donepezil—Alzheimer's disease	0.000215	0.00182	CcSEcCtD
Pimozide—Palpitations—Memantine—Alzheimer's disease	0.000215	0.00181	CcSEcCtD
Pimozide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000214	0.00181	CcSEcCtD
Pimozide—Loss of consciousness—Memantine—Alzheimer's disease	0.000214	0.0018	CcSEcCtD
Pimozide—Syncope—Rivastigmine—Alzheimer's disease	0.000213	0.0018	CcSEcCtD
Pimozide—DRD2—nervous system—Alzheimer's disease	0.000212	0.00432	CbGeAlD
Pimozide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000211	0.00178	CcSEcCtD
Pimozide—Convulsion—Memantine—Alzheimer's disease	0.000211	0.00178	CcSEcCtD
Pimozide—Palpitations—Rivastigmine—Alzheimer's disease	0.00021	0.00178	CcSEcCtD
Pimozide—Hypertension—Memantine—Alzheimer's disease	0.00021	0.00177	CcSEcCtD
Pimozide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000209	0.00177	CcSEcCtD
Pimozide—KCNH2—nervous system—Alzheimer's disease	0.000208	0.00425	CbGeAlD
Pimozide—Anorexia—Donepezil—Alzheimer's disease	0.000208	0.00176	CcSEcCtD
Pimozide—Chest pain—Memantine—Alzheimer's disease	0.000207	0.00175	CcSEcCtD
Pimozide—Myalgia—Memantine—Alzheimer's disease	0.000207	0.00175	CcSEcCtD
Pimozide—Convulsion—Rivastigmine—Alzheimer's disease	0.000206	0.00174	CcSEcCtD
Pimozide—Hypertension—Rivastigmine—Alzheimer's disease	0.000205	0.00173	CcSEcCtD
Pimozide—Hypotension—Donepezil—Alzheimer's disease	0.000204	0.00172	CcSEcCtD
Pimozide—Fluspirilene—SLC6A4—Alzheimer's disease	0.000204	0.0682	CrCbGaD
Pimozide—DRD2—central nervous system—Alzheimer's disease	0.000204	0.00416	CbGeAlD
Pimozide—Myalgia—Rivastigmine—Alzheimer's disease	0.000202	0.00171	CcSEcCtD
Pimozide—Chest pain—Rivastigmine—Alzheimer's disease	0.000202	0.00171	CcSEcCtD
Pimozide—Dry mouth—Memantine—Alzheimer's disease	0.000202	0.00171	CcSEcCtD
Pimozide—Asthenia—Galantamine—Alzheimer's disease	0.000202	0.00171	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000201	0.0017	CcSEcCtD
Pimozide—KCNH2—central nervous system—Alzheimer's disease	0.000201	0.00409	CbGeAlD
Pimozide—DRD2—cerebellum—Alzheimer's disease	0.000199	0.00406	CbGeAlD
Pimozide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000199	0.00168	CcSEcCtD
Pimozide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000198	0.00167	CcSEcCtD
Pimozide—Insomnia—Donepezil—Alzheimer's disease	0.000198	0.00167	CcSEcCtD
Pimozide—Astemizole—CYP2D6—Alzheimer's disease	0.000197	0.0659	CrCbGaD
Pimozide—KCNH2—cerebellum—Alzheimer's disease	0.000196	0.004	CbGeAlD
Pimozide—Shock—Memantine—Alzheimer's disease	0.000195	0.00165	CcSEcCtD
Pimozide—Nervous system disorder—Memantine—Alzheimer's disease	0.000194	0.00164	CcSEcCtD
Pimozide—Somnolence—Donepezil—Alzheimer's disease	0.000194	0.00164	CcSEcCtD
Pimozide—Tachycardia—Memantine—Alzheimer's disease	0.000194	0.00164	CcSEcCtD
Pimozide—Diarrhoea—Galantamine—Alzheimer's disease	0.000193	0.00163	CcSEcCtD
Pimozide—Skin disorder—Memantine—Alzheimer's disease	0.000193	0.00163	CcSEcCtD
Pimozide—Sertindole—HTR2A—Alzheimer's disease	0.000192	0.0643	CrCbGaD
Pimozide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000192	0.00162	CcSEcCtD
Pimozide—Shock—Rivastigmine—Alzheimer's disease	0.000191	0.00161	CcSEcCtD
Pimozide—ABCB1—embryo—Alzheimer's disease	0.00019	0.00389	CbGeAlD
Pimozide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00019	0.00161	CcSEcCtD
Pimozide—Decreased appetite—Donepezil—Alzheimer's disease	0.00019	0.0016	CcSEcCtD
Pimozide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000189	0.0016	CcSEcCtD
Pimozide—Anorexia—Memantine—Alzheimer's disease	0.000189	0.0016	CcSEcCtD
Pimozide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000189	0.00159	CcSEcCtD
Pimozide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000188	0.00159	CcSEcCtD
Pimozide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000188	0.00159	CcSEcCtD
Pimozide—Constipation—Donepezil—Alzheimer's disease	0.000187	0.00158	CcSEcCtD
Pimozide—Dizziness—Galantamine—Alzheimer's disease	0.000186	0.00158	CcSEcCtD
Pimozide—Hypotension—Memantine—Alzheimer's disease	0.000185	0.00157	CcSEcCtD
Pimozide—Anorexia—Rivastigmine—Alzheimer's disease	0.000185	0.00156	CcSEcCtD
Pimozide—Hypotension—Rivastigmine—Alzheimer's disease	0.000181	0.00153	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000181	0.00153	CcSEcCtD
Pimozide—Insomnia—Memantine—Alzheimer's disease	0.000179	0.00152	CcSEcCtD
Pimozide—Vomiting—Galantamine—Alzheimer's disease	0.000179	0.00151	CcSEcCtD
Pimozide—HTR1A—brain—Alzheimer's disease	0.000179	0.00365	CbGeAlD
Pimozide—Rash—Galantamine—Alzheimer's disease	0.000178	0.0015	CcSEcCtD
Pimozide—Dermatitis—Galantamine—Alzheimer's disease	0.000178	0.0015	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000177	0.00149	CcSEcCtD
Pimozide—Headache—Galantamine—Alzheimer's disease	0.000177	0.00149	CcSEcCtD
Pimozide—Somnolence—Memantine—Alzheimer's disease	0.000176	0.00149	CcSEcCtD
Pimozide—Sertindole—CYP2D6—Alzheimer's disease	0.000176	0.0588	CrCbGaD
Pimozide—CALM2—brain—Alzheimer's disease	0.000176	0.00359	CbGeAlD
Pimozide—Insomnia—Rivastigmine—Alzheimer's disease	0.000175	0.00148	CcSEcCtD
Pimozide—CALM1—brain—Alzheimer's disease	0.000175	0.00357	CbGeAlD
Pimozide—Urticaria—Donepezil—Alzheimer's disease	0.000174	0.00147	CcSEcCtD
Pimozide—Somnolence—Rivastigmine—Alzheimer's disease	0.000172	0.00146	CcSEcCtD
Pimozide—Decreased appetite—Memantine—Alzheimer's disease	0.000172	0.00146	CcSEcCtD
Pimozide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000171	0.00145	CcSEcCtD
Pimozide—Constipation—Memantine—Alzheimer's disease	0.00017	0.00143	CcSEcCtD
Pimozide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000169	0.00143	CcSEcCtD
Pimozide—ABCB1—forebrain—Alzheimer's disease	0.000168	0.00344	CbGeAlD
Pimozide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000168	0.00142	CcSEcCtD
Pimozide—Nausea—Galantamine—Alzheimer's disease	0.000167	0.00141	CcSEcCtD
Pimozide—HRH1—nervous system—Alzheimer's disease	0.000167	0.00341	CbGeAlD
Pimozide—Constipation—Rivastigmine—Alzheimer's disease	0.000166	0.0014	CcSEcCtD
Pimozide—DRD2—brain—Alzheimer's disease	0.000162	0.0033	CbGeAlD
Pimozide—HRH1—central nervous system—Alzheimer's disease	0.000161	0.00328	CbGeAlD
Pimozide—CYP2E1—nervous system—Alzheimer's disease	0.000161	0.00328	CbGeAlD
Pimozide—KCNH2—brain—Alzheimer's disease	0.000159	0.00325	CbGeAlD
Pimozide—Urticaria—Memantine—Alzheimer's disease	0.000158	0.00133	CcSEcCtD
Pimozide—Fluspirilene—HTR2A—Alzheimer's disease	0.000157	0.0524	CrCbGaD
Pimozide—Asthenia—Donepezil—Alzheimer's disease	0.000157	0.00132	CcSEcCtD
Pimozide—ABCB1—telencephalon—Alzheimer's disease	0.000155	0.00316	CbGeAlD
Pimozide—CYP2E1—central nervous system—Alzheimer's disease	0.000155	0.00315	CbGeAlD
Pimozide—Pruritus—Donepezil—Alzheimer's disease	0.000155	0.00131	CcSEcCtD
Pimozide—Urticaria—Rivastigmine—Alzheimer's disease	0.000154	0.0013	CcSEcCtD
Pimozide—CYP2E1—cerebellum—Alzheimer's disease	0.000151	0.00308	CbGeAlD
Pimozide—Diarrhoea—Donepezil—Alzheimer's disease	0.000149	0.00126	CcSEcCtD
Pimozide—Dizziness—Donepezil—Alzheimer's disease	0.000144	0.00122	CcSEcCtD
Pimozide—Asthenia—Memantine—Alzheimer's disease	0.000142	0.0012	CcSEcCtD
Pimozide—Fexofenadine—CYP2D6—Alzheimer's disease	0.000141	0.047	CrCbGaD
Pimozide—Pruritus—Memantine—Alzheimer's disease	0.00014	0.00119	CcSEcCtD
Pimozide—HTR2A—nervous system—Alzheimer's disease	0.00014	0.00285	CbGeAlD
Pimozide—Asthenia—Rivastigmine—Alzheimer's disease	0.000139	0.00118	CcSEcCtD
Pimozide—Vomiting—Donepezil—Alzheimer's disease	0.000139	0.00117	CcSEcCtD
Pimozide—Rash—Donepezil—Alzheimer's disease	0.000138	0.00116	CcSEcCtD
Pimozide—Dermatitis—Donepezil—Alzheimer's disease	0.000138	0.00116	CcSEcCtD
Pimozide—Pruritus—Rivastigmine—Alzheimer's disease	0.000137	0.00116	CcSEcCtD
Pimozide—Headache—Donepezil—Alzheimer's disease	0.000137	0.00116	CcSEcCtD
Pimozide—Diarrhoea—Memantine—Alzheimer's disease	0.000136	0.00115	CcSEcCtD
Pimozide—HTR2A—central nervous system—Alzheimer's disease	0.000134	0.00274	CbGeAlD
Pimozide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000133	0.00112	CcSEcCtD
Pimozide—HTR2A—cerebellum—Alzheimer's disease	0.000131	0.00268	CbGeAlD
Pimozide—Dizziness—Memantine—Alzheimer's disease	0.000131	0.00111	CcSEcCtD
Pimozide—Nausea—Donepezil—Alzheimer's disease	0.00013	0.0011	CcSEcCtD
Pimozide—CYP3A4—nervous system—Alzheimer's disease	0.000129	0.00264	CbGeAlD
Pimozide—Domperidone—CYP2D6—Alzheimer's disease	0.000128	0.0429	CrCbGaD
Pimozide—Dizziness—Rivastigmine—Alzheimer's disease	0.000128	0.00108	CcSEcCtD
Pimozide—HRH1—brain—Alzheimer's disease	0.000128	0.00261	CbGeAlD
Pimozide—CYP2D6—nervous system—Alzheimer's disease	0.000127	0.00259	CbGeAlD
Pimozide—Vomiting—Memantine—Alzheimer's disease	0.000126	0.00107	CcSEcCtD
Pimozide—Rash—Memantine—Alzheimer's disease	0.000125	0.00106	CcSEcCtD
Pimozide—Dermatitis—Memantine—Alzheimer's disease	0.000125	0.00106	CcSEcCtD
Pimozide—CYP3A4—central nervous system—Alzheimer's disease	0.000124	0.00254	CbGeAlD
Pimozide—Headache—Memantine—Alzheimer's disease	0.000124	0.00105	CcSEcCtD
Pimozide—Vomiting—Rivastigmine—Alzheimer's disease	0.000123	0.00104	CcSEcCtD
Pimozide—CYP2E1—brain—Alzheimer's disease	0.000123	0.0025	CbGeAlD
Pimozide—CYP2D6—central nervous system—Alzheimer's disease	0.000122	0.0025	CbGeAlD
Pimozide—Rash—Rivastigmine—Alzheimer's disease	0.000122	0.00103	CcSEcCtD
Pimozide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000122	0.00103	CcSEcCtD
Pimozide—Headache—Rivastigmine—Alzheimer's disease	0.000122	0.00103	CcSEcCtD
Pimozide—CYP2D6—cerebellum—Alzheimer's disease	0.00012	0.00244	CbGeAlD
Pimozide—Nausea—Memantine—Alzheimer's disease	0.000118	0.000996	CcSEcCtD
Pimozide—Flunarizine—CYP2D6—Alzheimer's disease	0.000116	0.0388	CrCbGaD
Pimozide—Nausea—Rivastigmine—Alzheimer's disease	0.000115	0.000974	CcSEcCtD
Pimozide—HTR2A—brain—Alzheimer's disease	0.000107	0.00218	CbGeAlD
Pimozide—CYP2D6—brain—Alzheimer's disease	9.72e-05	0.00198	CbGeAlD
Pimozide—ABCB1—nervous system—Alzheimer's disease	9.14e-05	0.00187	CbGeAlD
Pimozide—ABCB1—central nervous system—Alzheimer's disease	8.8e-05	0.0018	CbGeAlD
Pimozide—ABCB1—cerebellum—Alzheimer's disease	8.61e-05	0.00176	CbGeAlD
Pimozide—ABCB1—brain—Alzheimer's disease	6.99e-05	0.00143	CbGeAlD
Pimozide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.78e-06	1.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.78e-06	1.83e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.77e-06	1.82e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.77e-06	1.82e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—Alzheimer's disease	1.77e-06	1.82e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CAV1—Alzheimer's disease	1.77e-06	1.82e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—INS—Alzheimer's disease	1.76e-06	1.81e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—INS—Alzheimer's disease	1.76e-06	1.81e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—Alzheimer's disease	1.76e-06	1.81e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—AKT1—Alzheimer's disease	1.75e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—AKT1—Alzheimer's disease	1.75e-06	1.8e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.75e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—Alzheimer's disease	1.75e-06	1.8e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.74e-06	1.79e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.74e-06	1.79e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CALM1—Alzheimer's disease	1.73e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—LEP—Alzheimer's disease	1.73e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APOE—Alzheimer's disease	1.73e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—LEP—Alzheimer's disease	1.73e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APOE—Alzheimer's disease	1.73e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—Alzheimer's disease	1.71e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—Alzheimer's disease	1.71e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ESR1—Alzheimer's disease	1.7e-06	1.75e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—Alzheimer's disease	1.7e-06	1.75e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—Alzheimer's disease	1.7e-06	1.75e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.69e-06	1.74e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.69e-06	1.74e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—Alzheimer's disease	1.69e-06	1.74e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—Alzheimer's disease	1.69e-06	1.74e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.69e-06	1.73e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.68e-06	1.73e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—F2—Alzheimer's disease	1.68e-06	1.73e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.68e-06	1.73e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-06	1.72e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.67e-06	1.71e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.66e-06	1.71e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.66e-06	1.71e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.66e-06	1.7e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.66e-06	1.7e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ESR1—Alzheimer's disease	1.65e-06	1.7e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ESR1—Alzheimer's disease	1.65e-06	1.7e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.65e-06	1.69e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.64e-06	1.69e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.64e-06	1.68e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.64e-06	1.68e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—AKT1—Alzheimer's disease	1.63e-06	1.68e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—F2—Alzheimer's disease	1.63e-06	1.67e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—F2—Alzheimer's disease	1.63e-06	1.67e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.62e-06	1.67e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—APOE—Alzheimer's disease	1.62e-06	1.66e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MAPK8—Alzheimer's disease	1.61e-06	1.66e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.61e-06	1.66e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.61e-06	1.65e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.61e-06	1.65e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.61e-06	1.65e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.6e-06	1.65e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—NOS3—Alzheimer's disease	1.6e-06	1.64e-05	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.6e-06	1.64e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-06	1.64e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-06	1.64e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.58e-06	1.63e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	1.63e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—AKT1—Alzheimer's disease	1.58e-06	1.62e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—AKT1—Alzheimer's disease	1.58e-06	1.62e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.57e-06	1.62e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—AKT1—Alzheimer's disease	1.57e-06	1.61e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.56e-06	1.61e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK8—Alzheimer's disease	1.56e-06	1.61e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK8—Alzheimer's disease	1.56e-06	1.61e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.56e-06	1.6e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—Alzheimer's disease	1.55e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—Alzheimer's disease	1.55e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.55e-06	1.59e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.54e-06	1.58e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.54e-06	1.58e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CREB1—Alzheimer's disease	1.53e-06	1.58e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.53e-06	1.57e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—INS—Alzheimer's disease	1.52e-06	1.57e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.52e-06	1.57e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—AKT1—Alzheimer's disease	1.52e-06	1.56e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—AKT1—Alzheimer's disease	1.52e-06	1.56e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.52e-06	1.56e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.51e-06	1.55e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL2—Alzheimer's disease	1.5e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.5e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.5e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-06	1.53e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-06	1.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—INS—Alzheimer's disease	1.48e-06	1.52e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—INS—Alzheimer's disease	1.48e-06	1.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1—Alzheimer's disease	1.47e-06	1.52e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	1.51e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	1.51e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—Alzheimer's disease	1.46e-06	1.5e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.45e-06	1.5e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-06	1.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-06	1.49e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.45e-06	1.49e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.44e-06	1.48e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.43e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1—Alzheimer's disease	1.43e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1—Alzheimer's disease	1.43e-06	1.47e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—INS—Alzheimer's disease	1.42e-06	1.46e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	1.45e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-06	1.45e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.41e-06	1.45e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.4e-06	1.44e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.39e-06	1.43e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.39e-06	1.43e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.39e-06	1.43e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—INS—Alzheimer's disease	1.38e-06	1.42e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.38e-06	1.42e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.42e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.38e-06	1.42e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	1.41e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.37e-06	1.41e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-06	1.4e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.4e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.36e-06	1.39e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.36e-06	1.39e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.34e-06	1.38e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.38e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—Alzheimer's disease	1.34e-06	1.37e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1.37e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.33e-06	1.37e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.31e-06	1.34e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—INS—Alzheimer's disease	1.3e-06	1.34e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.3e-06	1.34e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.3e-06	1.33e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-06	1.33e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-06	1.33e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.29e-06	1.33e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.28e-06	1.32e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.28e-06	1.31e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.27e-06	1.31e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.31e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—Alzheimer's disease	1.26e-06	1.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.26e-06	1.29e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.26e-06	1.29e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-06	1.29e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.29e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.25e-06	1.29e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.24e-06	1.28e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	1.27e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.23e-06	1.27e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	1.27e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—Alzheimer's disease	1.22e-06	1.26e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—Alzheimer's disease	1.22e-06	1.26e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.21e-06	1.25e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.19e-06	1.22e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.18e-06	1.21e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.18e-06	1.21e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.21e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	1.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.16e-06	1.19e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.16e-06	1.19e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.14e-06	1.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	1.17e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.14e-06	1.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—Alzheimer's disease	1.14e-06	1.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—Alzheimer's disease	1.13e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.12e-06	1.16e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.14e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—INS—Alzheimer's disease	1.1e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-06	1.12e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-06	1.12e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.08e-06	1.11e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.08e-06	1.11e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.07e-06	1.1e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.07e-06	1.1e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-06	1.09e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.04e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.04e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.04e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—Alzheimer's disease	1.03e-06	1.06e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.02e-06	1.05e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.01e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.01e-06	1.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1e-06	1.03e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—Alzheimer's disease	9.97e-07	1.03e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—Alzheimer's disease	9.97e-07	1.03e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.97e-07	1.02e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.93e-07	1.02e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.88e-07	1.02e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	9.84e-07	1.01e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—Alzheimer's disease	9.68e-07	9.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—Alzheimer's disease	9.63e-07	9.91e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—Alzheimer's disease	9.52e-07	9.78e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—Alzheimer's disease	9.51e-07	9.78e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—Alzheimer's disease	9.32e-07	9.58e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—Alzheimer's disease	9.32e-07	9.58e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.29e-07	9.55e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—Alzheimer's disease	9.2e-07	9.46e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—Alzheimer's disease	9.2e-07	9.46e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—Alzheimer's disease	9.2e-07	9.46e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—Alzheimer's disease	9.2e-07	9.46e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—Alzheimer's disease	8.91e-07	9.16e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.85e-07	9.1e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—Alzheimer's disease	8.84e-07	9.09e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—Alzheimer's disease	8.78e-07	9.03e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	8.77e-07	9.02e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—Alzheimer's disease	8.75e-07	9e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.68e-07	8.93e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	8.61e-07	8.85e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.57e-07	8.81e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—Alzheimer's disease	8.55e-07	8.8e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—Alzheimer's disease	8.55e-07	8.8e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—INS—Alzheimer's disease	8.51e-07	8.76e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—Alzheimer's disease	8.49e-07	8.73e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—Alzheimer's disease	8.49e-07	8.73e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.16e-07	8.39e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.03e-07	8.25e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.01e-07	8.24e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	7.88e-07	8.1e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.53e-07	7.74e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.47e-07	7.68e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.41e-07	7.61e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—Alzheimer's disease	7.4e-07	7.61e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.39e-07	7.6e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.38e-07	7.59e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—Alzheimer's disease	7.35e-07	7.56e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—Alzheimer's disease	7.28e-07	7.48e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.27e-07	7.48e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—Alzheimer's disease	7.11e-07	7.31e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—Alzheimer's disease	7.11e-07	7.31e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—Alzheimer's disease	7.04e-07	7.24e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—Alzheimer's disease	7.04e-07	7.24e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.83e-07	7.02e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—Alzheimer's disease	6.66e-07	6.85e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—Alzheimer's disease	6.45e-07	6.63e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—Alzheimer's disease	6.45e-07	6.63e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—Alzheimer's disease	6.15e-07	6.32e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—Alzheimer's disease	5.95e-07	6.11e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—Alzheimer's disease	5.95e-07	6.11e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	5.71e-07	5.87e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.57e-07	5.73e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.25e-07	5.4e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.45e-07	4.57e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.43e-07	3.53e-06	CbGpPWpGaD
